Author
Ichiro Ono
Bio: Ichiro Ono is an academic researcher from Sapporo Medical University. The author has contributed to research in topics: Wound healing & Basic fibroblast growth factor. The author has an hindex of 27, co-authored 89 publications receiving 2070 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The results revealed that the alkali phosphatase (AL-P) activity of the pellets was elevated only in those of the bone morphogenetic protein group, and the increase in bone mineral density was the most remarkable in the bone Morphogenetic Protein group rather than the control group.
Abstract: Our present study consisted of an implantation of artificially made hydroxyapatite (HAP) ceramic pellets under the periosteum of the rabbit skull with subsequent inspection of further progress of bone formation and also of an evaluation of the effects of bone morphogenetic protein (BMP). The results revealed that the alkali phosphatase (AL-P) activity of the pellets was elevated only in those of the bone morphogenetic protein group. The results of determination of bone mineral density at the site of the pellets revealed that the increase in bone mineral density was the most remarkable in the bone morphogenetic protein group rather than the control group. The results of the histopathologic examinations revealed that marginal bone formation was found in the pores on the surface between the pellets and the skull in the control group and in the collagen group, whereas in the bone morphogenetic protein group very active bone formation was found not only on the interface in contact with the skull but also surrounding the whole pellet. It also was noted in the animals in the bone morphogenetic protein group that the pellets were corrupted from the peripheries and then absorbed into the newly formed bone. From these results, the efficacy of the hydroxyapatite-collagen-bone morphogenetic protein complex was made clear, and applications in clinical practice are expected in the near future.
122 citations
••
TL;DR: Postoperative administration of bFGF inhibited hypertrophic scarring and widening of remaining scars without any serious side effects.
Abstract: In order to identify a means to reduce scar formation of the skin after incision, this study examined the effect of local administration of basic fibroblast growth factor (bFGF) in humans. bFGF was administered to a sutured wound immediately after an operation. The drug was injected once into the dermis of the margins of wounds using a 27G needle or rinsing after performing dermostitches. The lengths of the treated wounds varied from 1 to 32 cm, and the subjects were 2-86 years old. Sutured wounds after excision of skin tumors from the face, trunk, and limbs and sutured wounds such as those at the donor sites of full-thickness skin grafts were treated with low-dose bFGF injections (0.1 microg/cm wound; Group 2), high-dose bFGF injections (1 microg/cm wound; Group 3), and rinsed with high-dose bFGF (1 microg/cm wound; Group 4). No patient treated with bFGF had hypertrophic scars, while some patients had hypertrophic or very wide scars in the control group (Group 1), and the ratios of minimum scarring of Group 2 (p<0.001), Group 3 (p<0.0001), and Group 4 (p<0.0001) were statistically significantly higher than those of Group 1. Postoperative administration of bFGF inhibited hypertrophic scarring and widening of remaining scars without any serious side effects.
110 citations
••
TL;DR: It is increased the likelihood that film or hydrocolloid dressings will be used more frequently in the future for treatment of burn wounds, ulcers or donor-site wounds since these dressings were shown to be more capable of retaining cytokines, particularly intrinsic growth factors secreted at the wound site.
103 citations
••
TL;DR: The three-dimensional (3D) deformities in patients with congenital facial anomalies, such as cleft lip and palate or hemifacial microsomia, are studied using 3D CT images and the 'skeletograms', which present deformities of craniofacial bones in detail as a 3D wire frame model, are prepared for detailed analysis of the cranioFacial bones' deformities.
Abstract: Summary We studied the three-dimensional (3D) deformities in patients with congenital facial anomalies, such as cleft lip and palate or hemifacial microsomia using three-dimensional CT (3DCT) images. At the same time, the data from the 3DCT was processed and analyzed using a 3DCT measurement system which we have recently developed. The coordinates of the 67 test points on the craniofacial bones were determined on a 3D image prepared by the 3DCT measurement system. Using this system, we prepared the ‘skeletograms’, which present deformities of craniofacial bones in detail as a 3D wire frame model, for detailed analysis of the craniofacial bones' deformities.
97 citations
••
TL;DR: The results confirm the clinical usefulness of gene therapy for bone formation, using the BMP-2 gene combined with cationic liposomes as a vector and it is possible that the effects of administering the B MP-2 genes will be improved by specializing the microstructure of scaffold for gene therapy.
92 citations
Cited by
More filters
••
TL;DR: This review summarizes the results of expression studies that have been performed in rodents, pigs, and humans to localize growth factors and their receptors in skin wounds and reports on genetic studies addressing the functions of endogenous growth factors in the wound repair process.
Abstract: Werner, Sabine, and Richard Grose. Regulation of Wound Healing by Growth Factors and Cytokines. Physiol Rev 83: 835–870, 2003; 10.1152/physrev.00032.2002.—Cutaneous wound healing is a complex proce...
3,234 citations
••
TL;DR: This review focuses on calcium phosphate-based bone substitute materials that are used (or can be used) for teeth or bone replacement, bone repair, augmentation, or regeneration and will also include some properties of bone (e.g., interconnected porosity, biodegradability, bioactivity, osteoconductivity) that are being mimicked in the manufacture of calcium phosphates.
Abstract: This review focuses on calcium phosphate-based bone substitute materials that are used (or can be used) for teeth or bone replacement, bone repair, augmentation, or regeneration. This review will also include some properties of bone (e.g., interconnected porosity, biodegradability, bioactivity, osteoconductivity) that are being mimicked in the manufacture of calcium phosphate-based biomaterials and some of the reported factors and strategies that can make the calcium phosphate-based biomaterials acquire osteoinductive properties. Archaeological findings showed that attempts to replace missing teeth date back to the prehistoric period. The materials used then included shells, corals, ivory (from elephant tusks), metals, and human (from corpses) and animal bones. Because of the practice of cremation in many societies, not much is known about prehistoric materials used to replace bones lost to accident or disease. Presently, autografts (bones obtained from another anatomic site in the same subject) remain the gold standard for bone repair, substitution, and augmentation followed by allografts (bones from another subject, such as processed cadaver bones). Autografts and allografts while having the important advantage of being osteogenic or osteoinductive (i.e., inducing bone formation), suffer from several disadvantages. With autografts the drawbacks include additional expense and trauma to the patient, possibility of donor site morbidity, and limited availability. In the case of allografts, in addition to limited supply and high cost, potential viral transmission and immunogenicity are of serious concern. Because of the high cost and limited availability of autografts and allografts, there is a great need to develop synthetic alternative biomaterials for bone replacement, repair, and augmentation. Current commercial substitute materials to replace or repair teeth and bones include metals, polymers (natural or synthetic), corals, human bones (processed cadaver bones), animal bones (processed cow bones), corals and coral derived, synthetic ceramics (calcium phosphates, calcium sulfates, calcium carbonate, bioactive glasses), and composites. It is interesting to note that several of the materials used in prehistoric times are similar to the materials used presently (e.g., coral and coral derived, animal bone derived, metals). Generally, depending on the ability to stimulate bone tissue, materials for tooth or bone repair or replacement are classified as bioinert or bioactive. Bioinert materials do not stimulate bone formation but instead stimulate formation of fibrous tissue and therefore do not directly bond to bone and thus form a weak biomaterial-bone interface. Bioactive materials stimulate bone tissue formation and therefore directly bond with bone and thus form a uniquely strong biomaterial-bone interface. Bioinert materials include metals (e.g., titanium or titanium alloys, stainless steel, cobalt-chromium, Co-Cr, alloys), some synthetic polymers (e.g., PEEK, Teflon-type), and some ceramics (e.g., alumina, * To whom correspondence should be addressed. Phone: (212) 998-9580. Fax: (212) 995-4244. E-mail: rzl1@nyu.edu. Racquel Zapanta LeGeros received her Ph.D. degree from New York University. She is currently a Professor and Associate Chair of the Department of Biomaterials and Biomimetics at New York University College of Dentistry. Her pioneering work was on substitution in the apatite structure and effect on properties. Her research interests includes biologic and synthetic apatites and related calcium phosphates, calcium phosphatebased biomaterials in the form of granules, scaffolds, cements, and coatings, and implant surface modifications. Her current research is on the development of calcium phosphate-based biomaterial for prevention of bone loss induced by diseases (e.g., osteoporosis), therapy (e.g., radiation), condition (e.g., mineral deficiency, immobility), and recovery of bone loss. She is married to Dr. John P. LeGeros and mother of Bernard, David, Katherine, and Alessandra. Chem. Rev. 2008, 108, 4742–4753 4742
1,042 citations
••
TL;DR: Current biomedical applications of calcium orthophosphate bioceramics include replacements for hips, knees, teeth, tendons and ligaments, as well as repair for periodontal disease, maxillofacial reconstruction, augmentation and stabilization of the jawbone, spinal fusion and bone fillers after tumor surgery.
1,019 citations
••
TL;DR: This review focuses on the role of keratinocyte-fibroblast interactions in the wound-healing process and the phenotype of fibroblasts from different tissues or body sites becomes better defined, so as to understand their individual contribution in wound healing in more detail and possibly explain different clinical outcomes.
1,009 citations
••
TL;DR: Mesenchymal stem cells are a highly regulated self-renewing population of cells with potent mechanisms to avoid allogeneic rejection in humans and in animal models.
Abstract: Adult bone marrow derived mesenchymal stem cells offer the potential to open a new frontier in medicine. Regenerative medicine aims to replace effete cells in a broad range of conditions associated with damaged cartilage, bone, muscle, tendon and ligament. However the normal process of immune rejection of mismatched allogeneic tissue would appear to prevent the realisation of such ambitions. In fact mesenchymal stem cells avoid allogeneic rejection in humans and in animal models. These finding are supported by in vitro co-culture studies. Three broad mechanisms contribute to this effect. Firstly, mesenchymal stem cells are hypoimmunogenic, often lacking MHC-II and costimulatory molecule expression. Secondly, these stem cells prevent T cell responses indirectly through modulation of dendritic cells and directly by disrupting NK as well as CD8+ and CD4+ T cell function. Thirdly, mesenchymal stem cells induce a suppressive local microenvironment through the production of prostaglandins and interleukin-10 as well as by the expression of indoleamine 2,3,-dioxygenase, which depletes the local milieu of tryptophan. Comparison is made to maternal tolerance of the fetal allograft, and contrasted with the immune evasion mechanisms of tumor cells. Mesenchymal stem cells are a highly regulated self-renewing population of cells with potent mechanisms to avoid allogeneic rejection.
850 citations